Four patients affected with keratoacanthoma have been treated with etretinate. In all the cases the tumors were either excessively large or located in peculiar sites. Etretinate was initially administered at the dosage of 1-1.3 mg/kg/die and then reduced at 0.3 mg/kg/die. All the tumors healed completely. During the treatment a slight cheilitis appeared in all the patients. One of them also experienced a transient hypertrigliceridemia and another an erythematous scaling dermatitis of the trunk and of palms.
Keratoacantoma: treatment with etretinate / Balato, Nicola; Monfrecola, Giuseppe; Patruno, C; Ayala, Fabio. - In: ANNALI ITALIANI DI DERMATOLOGIA CLINICA E SPERIMENTALE. - ISSN 0365-169X. - 46:4(1992), pp. 273-275.
Keratoacantoma: treatment with etretinate
BALATO, NICOLA;MONFRECOLA, GIUSEPPE;AYALA, FABIO
1992
Abstract
Four patients affected with keratoacanthoma have been treated with etretinate. In all the cases the tumors were either excessively large or located in peculiar sites. Etretinate was initially administered at the dosage of 1-1.3 mg/kg/die and then reduced at 0.3 mg/kg/die. All the tumors healed completely. During the treatment a slight cheilitis appeared in all the patients. One of them also experienced a transient hypertrigliceridemia and another an erythematous scaling dermatitis of the trunk and of palms.| File | Dimensione | Formato | |
|---|---|---|---|
|
Keratoacanthoma.docx
non disponibili
Tipologia:
Abstract
Licenza:
Accesso privato/ristretto
Dimensione
14.24 kB
Formato
Microsoft Word XML
|
14.24 kB | Microsoft Word XML | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
